NDC 0270-7097

Lumason

Sulfur Hexafluoride

Lumason is a Intravenous; Intravesical Injection, Powder, Lyophilized, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Bracco Diagnostics Inc. The primary component is Sulfur Hexafluoride; Distearoylphosphatidylcholine, Dl-; Sodium 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol).

Product ID0270-7097_1db2a528-010c-45f0-b620-7b90ac1aca8b
NDC0270-7097
Product TypeHuman Prescription Drug
Proprietary NameLumason
Generic NameSulfur Hexafluoride
Dosage FormInjection, Powder, Lyophilized, For Suspension
Route of AdministrationINTRAVENOUS; INTRAVESICAL
Marketing Start Date2021-04-01
Marketing CategoryNDA /
Application NumberNDA203684
Labeler NameBRACCO DIAGNOSTICS INC
Substance NameSULFUR HEXAFLUORIDE; DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL)
Active Ingredient Strength61 mg/mg; mg/mg; mg/mg
Pharm ClassesContrast Agent for Ultrasound Imaging [EPC],Ultrasound Contrast Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0270-7097-08

20 VIAL in 1 BOX (0270-7097-08) > 25 mg in 1 VIAL
Marketing Start Date2021-04-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lumason" or generic name "Sulfur Hexafluoride"

NDCBrand NameGeneric Name
0270-7097LumasonSULFUR HEXAFLUORIDE
0270-7099LumaSonSULFUR HEXAFLUORIDE
68155-099LumaSonSULFUR HEXAFLUORIDE

Trademark Results [Lumason]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LUMASON
LUMASON
88284789 5834181 Live/Registered
Bracco Diagnostics Inc.
2019-01-31
LUMASON
LUMASON
85929727 4786320 Live/Registered
Bracco Diagnostics Inc.
2013-05-13

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.